8-K//Current report
Aimmune Therapeutics, Inc. 8-K
Accession 0001564590-20-024181
CIK 0001631650operating
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:09 PM ET
Size
506.9 KB
Accession
0001564590-20-024181
Documents
- 8-Kaimt-8k_20200511.htmPrimary
8-K
- EX-99.1aimt-ex991_6.htm
EX-99.1
- GRAPHICguxpuy5smnsx000001.jpg
GRAPHIC
- EX-101.SCHaimt-20200511.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABaimt-20200511_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREaimt-20200511_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLaimt-8k_20200511_htm.xml
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- ZIP0001564590-20-024181-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001631650
Filing Metadata
- Form type
- 8-K
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:09 PM ET
- Size
- 506.9 KB